Faruqi & Faruqi, LLP is Investigating Anthera Pharmaceuticals Incorporated on
Behalf of its Shareholders - ANTH
NEW YORK, Feb. 13, 2013
NEW YORK, Feb. 13, 2013 /PRNewswire/ --Faruqi & Faruqi, LLP, a national law
firm concentrating on investor rights, consumer rights and the enforcement of
federal antitrust laws, is investigating potential claims against the board of
directors of Anthera Pharmaceuticals Incorporated ("Anthera" or the "Company")
(Nasdaq: ANTH) concerning possible breaches of fiduciary duty and other
violations of law related to the Company's compensation packages for its
executive officers. The investigation focuses on the approval and awarding of
certain stock options to executives that may have violated the Company's
Request more information now by clicking here: www.faruqilaw.com/ANTH
Faruqi & Faruqi, LLP is a national law firm which represents investors and
individuals in class action and derivative litigation. The firm is focused on
providing exemplary legal services in the areas of securities, shareholder,
antitrust and consumer litigation, through all phases of litigation. The firm
has an experienced trial team which has achieved significant victories on
behalf of the firm's clients.
If you hold ANTH shares and you would like to discuss your legal rights, visit
www.faruqilaw.com/ANTH. You can also contact us by calling Michael J. Hynes
free at 877-247-4292 or at 215-277-5770 or by sending an e-mail to
Faruqi & Faruqi, LLP
Michael J. Hynes, Esq.
101 Greenwood Avenue Suite 600
Jenkintown, PA 19046
Telephone: (877) 247-4292 or (215) 277-5770
Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible
for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior
results do not guarantee or predict a similar outcome with respect to any
future matter. We welcome the opportunity to discuss your particular case.
All communications will be treated in a confidential manner.
SOURCE Faruqi & Faruqi, LLP
Press spacebar to pause and continue. Press esc to stop.